Using maternal and neonatal data collection systems for coronavirus disease 2019 (COVID-19) vaccines active safety
Veronica Pingray1, María Belizán1, Sarah Matthews2
1Institute for Clinical Effectiveness and Health Policy (IECS-CONICET), Ciudad de Buenos Aires, Buenos Aires, 1414, Argentina.
Insights
Experts recommend using existing maternal and neonatal data systems for COVID-19 vaccine safety surveillance in low- and middle-income countries (LMICs). A consensus was reached on a core set of 14 variables for this critical public health surveillance.
Area of Science:
- Public Health
- Vaccinology
- Epidemiology
Background:
- Pregnant women are now eligible for COVID-19 vaccines, necessitating robust safety surveillance systems.
- Existing maternal and neonatal data collection systems in LMICs are potential resources for this surveillance.
- Ensuring vaccine safety in diverse populations, including pregnant women in LMICs, is crucial.
Purpose of the Study:
- To achieve consensus on utilizing LMIC maternal/neonatal data systems for COVID-19 vaccine safety surveillance.
- To define a core set of variables for this surveillance.
- To assess the suitability and feasibility of including pregnant women and LMIC networks in vaccine research.
Main Methods:
- A three-stage modified Delphi study was conducted over three months in 2020.
- An international multidisciplinary panel of 16 experts participated.
- Consensus was determined by analyzing rating distributions and rationale.
Main Results:
- The panel recommended using existing maternal and neonatal data systems for surveillance in LMICs.
- Consensus was achieved on a basic set of 14 maternal, neonatal, and vaccination variables.
- Inclusion of pregnant women in vaccine research was deemed appropriate, though feasibility faced uncertainties regarding decision-maker acceptability and regulatory aspects.
Conclusions:
- Maternal and neonatal data collection systems are recommended for COVID-19 vaccine safety surveillance in LMICs.
- A common set of 14 variables was agreed upon for effective surveillance.
- While feasibility challenges exist, the proposed approach supports vaccine safety monitoring in vulnerable populations and settings.
Abstract:
Background: Given that pregnant women are now included among those for receipt coronavirus disease 2019 (COVID-19) vaccines, it is important to ensure that information systems can be used (or available) for active safety surveillance, especially in low- and middle-income countries (LMICs). The aim of this study was to build consensus about the use of existing maternal and neonatal data collection systems in LMICs for COVID-19 vaccines active safety surveillance, a basic set of variables, and the suitability and feasibility of including pregnant women and LMIC research networks in COVID-19 vaccines pre-licensure activities. Methods: A three-stage modified Delphi study was conducted over three months in 2020. An international multidisciplinary panel of 16 experts participated. Ratings distributions and consensus were assessed, and ratings' rationale was analyzed. Results: The panel recommended using maternal and neonatal data collection systems for active safety surveillance in LMICs (median 9; disagreement index [DI] -0.92), but there was no consensus (median 6; DI 1.79) on the feasibility of adapting these systems. A basic set of 14 maternal, neonatal, and vaccination-related variables. Out of 16 experts, 11 supported a basic set of 14 maternal, neonatal, and vaccination-related variables for active safety surveillance. Seven experts agreed on a broader set of 26 variables. The inclusion of pregnant women for COVID-19 vaccines research (median 8; DI -0.61) was found appropriate, although there was uncertainty on its feasibility in terms of decision-makers' acceptability (median 7; DI 10.00) and regulatory requirements (median 6; DI 0.51). There was no consensus (median 6; DI 2.35) on the feasibility of including research networks in LMICs for conducting clinical trials amongst pregnant women. Conclusions: Although there was some uncertainty regarding feasibility, experts recommended using maternal and neonatal data collection systems and agreed on a common set of variables for COVID-19 vaccines active safety surveillance in LMICs.
More Related Videos
Related Concept Videos
Principles of Disease Surveillance
Data Collection I


